Nitromint (Glyceryl Trinitrate)

After sublingual administration, glyceryl trinitrate is converted to nitric oxide in vascular smooth‑muscle cells. Nitric oxide activates soluble guanylate cyclase, raising cyclic GMP levels, which relaxes smooth muscle in veins and arteries. This reduces cardiac preload and afterload and dilates coronary arteries, enhancing myocardial oxygen delivery.

The specific dose of Nitromint is determined by the prescribing clinician based on the individual’s clinical condition, severity of symptoms, and response to therapy. Typical sublingual tablets are taken at the onset of chest pain, but exact dosing frequency and amount must follow the prescriber’s instructions.

The pregnancy category for glyceryl trinitrate is listed as unknown. Use during pregnancy or lactation should only occur when the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss potential risks with the patient.

To request Nitromint, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Nitromint belongs to the nitrate class, providing rapid relief of angina through vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act more quickly but may cause tolerance with frequent use. Unlike long‑acting agents, sublingual nitroglycerin is reserved for acute attacks, while other classes are often used for chronic control.

Nitromint tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture, heat and direct sunlight. Do not store in bathrooms or near sources of humidity, and keep out of reach of children.

Nitromint is a sublingual tablet. Place the tablet under the tongue and allow it to dissolve completely; do not chew or swallow it. The medication is absorbed through the oral mucosa, providing rapid onset of action within minutes. If chest pain persists after the first dose, follow the prescriber’s instructions regarding additional dosing.

The most serious adverse events include severe hypotension, syncope, and methemoglobinemia, which can impair oxygen delivery. Patients should be alert for sudden dizziness, fainting, or a bluish discoloration of the skin or lips. Immediate medical attention is required if any of these symptoms occur.

Nitromint is contraindicated in patients with known hypersensitivity to nitrates, those taking phosphodiesterase‑5 inhibitors (e.g., sildenafil) due to risk of profound hypotension, and individuals with severe anemia, uncontrolled hypotension, or recent head trauma. Clinicians should also avoid use in patients with increased intracranial pressure or those who have had a recent myocardial infarction without proper evaluation.